We found that TUG1 acts as a competing endogenous RNA (ceRNA) that binds miR-145 and prevents downregulation of Sirt3 and GDH, leading to aberrant glutamine metabolism and ICC progression. This evidence concerns the gene TUG1 and intrahepatic cholangiocarcinoma.